1. Home
  2. BLFS vs BTX Comparison

BLFS vs BTX Comparison

Compare BLFS & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • BTX
  • Stock Information
  • Founded
  • BLFS 1987
  • BTX N/A
  • Country
  • BLFS United States
  • BTX United States
  • Employees
  • BLFS N/A
  • BTX N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • BTX
  • Sector
  • BLFS Health Care
  • BTX
  • Exchange
  • BLFS Nasdaq
  • BTX Nasdaq
  • Market Cap
  • BLFS 1.2B
  • BTX 1.3B
  • IPO Year
  • BLFS 1989
  • BTX N/A
  • Fundamental
  • Price
  • BLFS $23.29
  • BTX $6.51
  • Analyst Decision
  • BLFS Strong Buy
  • BTX
  • Analyst Count
  • BLFS 7
  • BTX 0
  • Target Price
  • BLFS $30.57
  • BTX N/A
  • AVG Volume (30 Days)
  • BLFS 573.8K
  • BTX 590.5K
  • Earning Date
  • BLFS 05-08-2025
  • BTX 01-01-0001
  • Dividend Yield
  • BLFS N/A
  • BTX 6.55%
  • EPS Growth
  • BLFS N/A
  • BTX N/A
  • EPS
  • BLFS N/A
  • BTX N/A
  • Revenue
  • BLFS $87,762,000.00
  • BTX N/A
  • Revenue This Year
  • BLFS $20.32
  • BTX N/A
  • Revenue Next Year
  • BLFS $19.98
  • BTX N/A
  • P/E Ratio
  • BLFS N/A
  • BTX N/A
  • Revenue Growth
  • BLFS N/A
  • BTX N/A
  • 52 Week Low
  • BLFS $17.15
  • BTX $5.10
  • 52 Week High
  • BLFS $29.55
  • BTX $8.31
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 49.30
  • BTX N/A
  • Support Level
  • BLFS $21.13
  • BTX N/A
  • Resistance Level
  • BLFS $25.60
  • BTX N/A
  • Average True Range (ATR)
  • BLFS 1.58
  • BTX 0.00
  • MACD
  • BLFS -0.07
  • BTX 0.00
  • Stochastic Oscillator
  • BLFS 48.32
  • BTX 0.00

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About BTX BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest

BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.

Share on Social Networks: